A Big Difference In Supply Chain Management Using Little's Law

Maintaining a robust, reliable supply chain is crucial for companies manufacturing cell and gene therapies (CGTs) to reduce risk of delays and ensure the stability and efficacy of time and temperature sensitive materials. Supply chain disruptions over the past years and the CGT industry’s reliance on a combination of single use products and stainless steel, complex manufacturing practices, and regulatory complexity create unique demands when compared to other industries.

Monitoring the product shelf life, necessary testing, validation, and regulatory requirements for CGT products requires a coordinated effort from supply chain personnel and quality assurance associates. Utilizing a proactive solution such as Little’s Law can help teams to avoid costly delays and streamline the supply chain management process. However, the limitations common to Little’s Law often require the expertise of a supply chain professional to enable a tailored approach for different warehouses. Learn how leveraging Little’s Law to quantify metrics that otherwise would be causing confusion and process interruption can help to reduce wait time and deliver materials on-time and within budget.